The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Pre-clinical analysis of the CDK4/6 inhibitor palbociclib in HER2-positive breast cancer.

Bilal  ElChaarani

No Relationships to Disclose

Hillary  Stires

No Relationships to Disclose

Paula Raffin  Pohlmann

Leadership - Immunonet BioSciences

Stock and Other Ownership Interests  - Immunonet BioSciences

Consulting or Advisory Role - Immunonet BioSciences; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer

Patents, Royalties, Other Intellectual Property - IMMUNOLOGICAL COMPOSITIONS AS CANCER BIOMARKERS AND/OR THERAPEUTICS; U.S. Patent and Trademark Office No. US 20120201820. Invention title: Immunological Compositions as Cancer Therapeutics.

Rebecca  Riggins

No Relationships to Disclose